# OnCo record progensa-pca3 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/progensa-pca3/>
  a schema:MedicalTest ;
  onco:kind "drug" ;
  schema:identifier "progensa-pca3" ;
  schema:name "Progensa PCA3 Assay"@en ;
  schema:alternateName "PCA3 urine test"@en, "Progensa"@en, "Progensa PCA3" ;
  schema:description "The first urine RNA test for prostate cancer approved in the United States; its approval has since been withdrawn, though Medicare still lists it."@en ;
  schema:url <https://onco.cc/drugs/progensa-pca3/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=P100033>, <https://www.cms.gov/medicare-coverage-database/view/article.aspx?articleid=58700> ;
  onco:status "withdrawn" ;
  onco:tag "test", "rna" ;
  onco:modality "Urine RNA test (PCA3 and PSA RNA, after a negative biopsy)" ;
  onco:approval "US 2012: FDA PMA approval (P100033) of a urine PCA3 RNA test to aid the decision on repeat biopsy for prostate cancer; withdrawn 12 April 2023" ;
  onco:related <https://onco.cc/drugs/exodx-prostate/> ;
  onco:cancers <https://onco.cc/cancers/prostate/> ;
  onco:technologies <https://onco.cc/technologies/liquid-rna-biopsy/> .